Inventor · disambiguated record
Fred Hofmann
Also filed as: HOFMANN FRED
12 granted patents·6 pending applications·35 citations·filing 2002–2021
88Inventor score
Top patents by PatentIndex Score
18 records- 0192US9827298B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Nov 28, 2017·10 cites·4 claims
- 0290US9975929B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted May 22, 2018·6 cites·3 claims
- 0386US9511114B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Dec 6, 2016·5 cites·5 claims
- 0483US10603353B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted Mar 31, 2020·2 cites·27 claims
- 0580US9193771B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Nov 24, 2015·3 cites·3 claims
- 0679US9809809B2Neurotoxins exhibiting shortened biological activityMERZ PHARMA GMBH & CO KGAA·Filed 2012·Granted Nov 7, 2017·6 cites·17 claims
- 0775US11357821B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2019·Granted Jun 14, 2022·1 cites·23 claims
- 0870US11078472B2Recombinant clostridial neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Aug 3, 2021·1 cites·17 claims
- 0966US8586329B2Neurotoxins exhibiting shortened biological activityHOFMANN FRED·Filed 2010·Granted Nov 19, 2013·1 cites·11 claims
- 1061US2022010294A1Novel recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2021·Application pending·0 cites
- 1154US11155802B2Recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Oct 26, 2021·0 cites·13 claims
- 1243US2015322118A1Recombinant clostridial neurotoxins with enhanced membrane localizationMERZ PHARMA GMBH & CO KGAA·Filed 2013·Application pending·0 cites
- 1342US2021008156A1Novel recombinant botulinum neurotoxins with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Application pending·0 cites
- 1441US11952601B2Recombinant botulinum toxin with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Apr 9, 2024·0 cites·16 claims
- 1539US2020354706A1Novel recombinant botulinum toxin with increased duration of effectMERZ PHARMA GMBH & CO KGAA·Filed 2017·Application pending·0 cites
- 1639US2015232828A1Method for the manufacturing of recombinant proteins harbouring an n-terminal lysineMERZ PHARMA GMBH & CO KGAA·Filed 2013·Application pending·0 cites
- 1724US8747841B2Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injuryAHNERT-HILGER GUDRUN·Filed 2010·Granted Jun 10, 2014·0 cites·13 claims
- 1823US2005255543A1Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regenerationJUST INGO·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fred Hofmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →